Draft qualification opinion of clinically interpretable treatment effect measures based on recurrent event endpoints that allow for efficient statistical analyses: Call for comments to EMA

Group to promote the use of recurrent data in clinical trials

Research output: Contribution to memorandum/expositionMemorandum contribution

Original languageEnglish
Publication date2019
Publication statusPublished - 2019

Bibliographical note

EMA/CHMP/SAWP/291384/2019

Cite this